Skip to content

Models 011 & 011B Iridocapsular IOLs

by Pharmacia, Inc.

PMA P810042

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P810042↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP810042 Date15 Dec 1982ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic Name
intraocular lens
PMA Number
FDA Product Code
HQL
Device Class
Class III
Regulation
21 CFR Part 886.3600
Advisory Committee
Ophthalmic
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Models 011 & 011B Iridocapsular IOLs are intraocular lenses designed for implantation within the capsular bag of the eye following cataract surgery. These devices restore visual function by replacing the natural lens, providing optical correction for aphakia while maintaining alignment within the capsular structure.

These lenses are supplied sterile and intended for single-use in ophthalmic surgical settings. They are classified as Class III devices under FDA regulations and were authorized via a Premarket Approval (PMA) application (PMA Number: P810042). No specific MRI safety information is provided, and storage conditions are not detailed in the submitted data.

Other devices from Pharmacia, Inc.

See all devices from Pharmacia, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Models 011 & 011B Iridocapsular IOLs, and how do they function in cataract surgery?

    The Models 011 & 011B Iridocapsular IOLs are designed to replace the natural lens of the eye following cataract surgery. They are implanted within the capsular bag to restore visual function by providing optical correction for aphakia (absence of a lens). These lenses maintain alignment within the capsular structure, ensuring stable positioning for clear vision.

  • Are the Models 011 & 011B Iridocapsular IOLs intended for reuse, or are they single-use devices?

    The Models 011 & 011B Iridocapsular IOLs are explicitly labeled as intended for single-use in ophthalmic surgical settings. This designation ensures sterility and safety for each patient, reducing the risk of infection or contamination.

  • How were these devices authorized for use in the United States, and what regulatory classification do they hold?

    The Models 011 & 011B Iridocapsular IOLs were authorized via a Premarket Approval (PMA) application (PMA Number: P810042) by the FDA. They are classified as Class III devices, which is the highest regulatory classification for medical devices requiring a rigorous approval process due to their critical role in patient safety and effectiveness.

  • What storage conditions should be considered for these intraocular lenses, and are they provided sterile?

    The Models 011 & 011B Iridocapsular IOLs are supplied sterile, ensuring they are ready for immediate use in surgical settings. However, the provided data does not specify detailed storage conditions, so it is important to follow manufacturer guidelines or best practices to maintain sterility and integrity until use.